Details for New Drug Application (NDA): 021994
✉ Email this page to a colleague
The generic ingredient in TRAVATAN Z is travoprost. There are fifteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the travoprost profile page.
Summary for 021994
Tradename: | TRAVATAN Z |
Applicant: | Sandoz |
Ingredient: | travoprost |
Patents: | 3 |
Suppliers and Packaging for NDA: 021994
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994 | NDA | Novartis Pharmaceuticals Corporation | 0078-0946 | 0078-0946-25 | 1 BOTTLE in 1 CARTON (0078-0946-25) / 5 mL in 1 BOTTLE |
TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994 | NDA | Novartis Pharmaceuticals Corporation | 0078-0946 | 0078-0946-40 | 1 BOTTLE in 1 CARTON (0078-0946-40) / 2.5 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.004% | ||||
Approval Date: | Sep 21, 2006 | TE: | AT | RLD: | Yes | ||||
Patent: | 8,268,299 | Patent Expiration: | Oct 13, 2029 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | 8,323,630 | Patent Expiration: | Sep 20, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | 8,388,941 | Patent Expiration: | Sep 20, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 021994
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | 5,510,383 | ⤷ Subscribe |
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | 6,849,253 | ⤷ Subscribe |
Sandoz | TRAVATAN Z | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021994-001 | Sep 21, 2006 | 6,503,497 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription